KCNJ13: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
'''KCNJ13''' is a gene that encodes the protein | |||
{{Infobox gene | |||
| name = KCNJ13 | |||
| symbol = KCNJ13 | |||
| HGNCid = 6251 | |||
| OMIM = 603208 | |||
| EntrezGene = 3769 | |||
| RefSeq = NM_002242 | |||
| UniProt = O60928 | |||
| chromosome = 2 | |||
| arm = q | |||
| band = 37 | |||
}} | |||
'''KCNJ13''' is a gene that encodes the protein known as '''inward rectifier potassium channel 13'''. This protein is part of the [[potassium channel]] family, which plays a crucial role in maintaining the [[membrane potential]] of cells. | |||
== Function == | == Function == | ||
The KCNJ13 gene | The KCNJ13 gene product is involved in the regulation of [[potassium ion]] flow into cells. It is particularly important in the [[retina]], where it helps to maintain the [[ionic balance]] necessary for [[photoreceptor]] function. Mutations in this gene can lead to [[retinal dystrophy]] and other [[ocular disorders]]. | ||
Mutations in | |||
== Clinical Significance == | |||
Mutations in the KCNJ13 gene have been associated with [[Leber congenital amaurosis]] (LCA), a severe [[retinal degenerative disease]] that leads to [[blindness]] at an early age. Studies have shown that these mutations disrupt the normal function of the potassium channel, leading to [[photoreceptor cell]] death. | |||
== Research == | == Research == | ||
Ongoing research is focused on understanding the precise mechanisms by which KCNJ13 mutations lead to retinal degeneration. There is also interest in developing [[gene therapy]] approaches to correct these mutations and restore normal function to the affected cells. | |||
[[ | |||
== See | == See Also == | ||
* [[ | * [[Potassium channel]] | ||
* [[Retinal dystrophy]] | |||
* [[Leber congenital amaurosis]] | * [[Leber congenital amaurosis]] | ||
== References == | == References == | ||
<references /> | <references /> | ||
[ | == External Links == | ||
[ | * [https://www.ncbi.nlm.nih.gov/gene/3769 KCNJ13 Gene - NCBI] | ||
[[Category: | * [https://www.omim.org/entry/603208 KCNJ13 - OMIM] | ||
[[Category:Genes on human chromosome 2]] | |||
[[Category:Potassium channels]] | [[Category:Potassium channels]] | ||
[[Category:Retinal diseases]] | |||
Latest revision as of 20:20, 30 December 2024
| Symbol | KCNJ13 |
|---|---|
| HGNC ID | 6251 |
| Alternative symbols | – |
| Entrez Gene | 3769 |
| OMIM | 603208 |
| RefSeq | NM_002242 |
| UniProt | O60928 |
| Chromosome | 2q37 |
| Locus supplementary data | – |
KCNJ13 is a gene that encodes the protein known as inward rectifier potassium channel 13. This protein is part of the potassium channel family, which plays a crucial role in maintaining the membrane potential of cells.
Function[edit]
The KCNJ13 gene product is involved in the regulation of potassium ion flow into cells. It is particularly important in the retina, where it helps to maintain the ionic balance necessary for photoreceptor function. Mutations in this gene can lead to retinal dystrophy and other ocular disorders.
Clinical Significance[edit]
Mutations in the KCNJ13 gene have been associated with Leber congenital amaurosis (LCA), a severe retinal degenerative disease that leads to blindness at an early age. Studies have shown that these mutations disrupt the normal function of the potassium channel, leading to photoreceptor cell death.
Research[edit]
Ongoing research is focused on understanding the precise mechanisms by which KCNJ13 mutations lead to retinal degeneration. There is also interest in developing gene therapy approaches to correct these mutations and restore normal function to the affected cells.
See Also[edit]
References[edit]
<references />